| Literature DB >> 35743467 |
Shingo Morishita1,2, Toshitaka Yoshii1, Hiroyuki Inose1, Takashi Hirai1, Yu Matsukura1, Takahisa Ogawa1, Kiyohide Fushimi3, Junya Katayanagi2, Tetsuya Jinno2, Atsushi Okawa1.
Abstract
For ossification of the posterior longitudinal ligament (OPLL) and cervical spondylotic myelopathy (CSM), anterior decompression with fusion (ADF) can accurately achieve spinal decompression. However, the difference in perioperative complications in ADF between OPLL and CSM is poorly described. This study aimed to investigate the perioperative complication rates of patients with degenerative cervical myelopathy undergoing ADF, represented by OPLL and CSM, using a large national inpatient database. In the OPLL and CSM groups, postoperative complication (systemic and local) rates, reoperation rates, medical costs during hospitalization, and mortality after propensity score matching were compared. After matching, 1197 matched pairs were made. The incidence of total systemic complications was similar between both groups (OPLL, 12.4%; CSM, 12.2%). In the OPLL group, more perioperative local complications (cerebrospinal fluid leakage: CSFL, [OPLL, 2.7%; CSM, 0.3%] and surgical site infection: SSI [OPLL, 2.1%; CSM, 0.9%]) were detected, and the hospitalization cost was approximately $3200 higher than that in the CSM group. Moreover, medical costs were significantly higher in patients who experienced complications in both OPLL and CSM. The frequency of perioperative complications of OPLL and CSM in ADF was detailed using large real-world data. Compared to CSM, OPLL had more perioperative complications such as CSFL and SSI, and higher medical costs. Regardless of the disease, medical costs were significantly increased when perioperative complications occurred.Entities:
Keywords: anterior decompression with fusion; cervical ossification of the longitudinal ligament; cervical spondylotic myelopathy; costs; diagnosis procedure combination database; perioperative complications
Year: 2022 PMID: 35743467 PMCID: PMC9225569 DOI: 10.3390/jcm11123398
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Patient characteristics between OPLL and CSM before and after matching.
| Before Propensity Score-Matching | After Propensity Score-Matching | |||||
|---|---|---|---|---|---|---|
| OPLL ( | CSM ( | OPLL ( | CSM ( | |||
| Age (years) | 60.3 ± 11.3 | 62.6 ± 13.0 | <0.001 *** | 61.3 ± 10.9 | 60.8 ± 12.9 | 0.35 |
| Sex | 0.60 | 0.89 | ||||
| Male | 948 (71.1%) | 1166 (70.2%) | 854 (71.4%) | 857 (71.6%) | ||
| Female | 385 (28.9%) | 494 (29.8%) | 343 (28.6%) | 340 (28.4%) | ||
| BMI (kg/m2) | 25.2 ± 4.2 | 23.8 ± 3.9 | <0.001 *** | 24.4 ± 3.2 | 24.7 ± 3.7 | 0.11 |
| Smoking | 0.99 | 0.41 | ||||
| Yes | 682 (51.2%) | 849 (51.1%) | 615 (51.4%) | 635 (53.0%) | ||
| No | 651 (48.8%) | 811 (48.9%) | 582 (48.6%) | 562 (47.0%) | ||
| Admission type | 0.018 * | 0.33 | ||||
| Scheduled | 1244 (93.3%) | 1510 (91.0%) | 1111 (92.8%) | 1123 (93.8%) | ||
| Unscheduled | 89 (6.7%) | 150 (9.0%) | 86 (7.2%) | 74 (6.2%) | ||
| Emergency transport | 0.012 * | 0.61 | ||||
| Yes | 19 (1.4%) | 46 (2.8%) | 19 (1.6%) | 16 (1.3%) | ||
| No | 1313 (98.6%) | 1614 (97.2%) | 1178 (98.4%) | 1181 (98.7%) | ||
| Hospital type | 0.99 | 0.96 | ||||
| Academic | 243 (18.2%) | 303 (18.2%) | 215 (18.0%) | 214 (17.9%) | ||
| Non-academic | 1090 (81.8%) | 1357 (81.8%) | 982 (82.0%) | 983 (82.1%) | ||
| ADL score for admission (points) | 17.3 ± 5.0 | 17.0 ± 5.5 | 0.23 | 17.2 ± 5.1 | 17.3 ± 5.2 | 0.75 |
| Preoperative comorbidities | ||||||
| Diabetes mellitus | 296 (22.2%) | 334 (20.1%) | 0.16 | 253 (21.1%) | 255 (21.3%) | 0.92 |
| Cardiovascular disease | 60 (4.5%) | 105 (6.3%) | 0.030 * | 57 (4.8%) | 65 (5.4%) | 0.46 |
| Cerebrovascular disease | 31 (2.3%) | 46 (2.8%) | 0.44 | 31 (2.6%) | 27 (2.3%) | 0.60 |
| Respiratory disease | 7 (0.5%) | 21 (1.3%) | 0.037 * | 7 (0.6%) | 7 (0.6%) | >0.99 |
| Renal failure | 13 (1.0%) | 46 (2.8%) | <0.001 *** | 12 (1.0%) | 12 (1.0%) | >0.99 |
| Hepatic failure | 39 (2.9%) | 53 (3.2%) | 0.67 | 38 (3.2%) | 36 (3.0%) | 0.81 |
| Gastric ulcer and hemorrhage | 48 (3.6%) | 64 (3.9%) | 0.72 | 43 (3.6%) | 43 (3.6%) | >0.99 |
| Malignancy | 8 (0.6%) | 24 (1.5%) | 0.025 * | 8 (0.7%) | 4 (0.3%) | 0.25 |
| Rheumatoid arthritis | 3 (0.2%) | 12 (0.7%) | 0.06 | 3 (0.3%) | 8 (0.7%) | 0.13 |
| Osteoporosis | 21 (1.6%) | 51 (3.1%) | 0.008 ** | 20 (1.7%) | 18 (1.5%) | 0.74 |
Data were presented as n (%) or mean ± SD. Significant values are given as follows. * p < 0.05, ** p < 0.01, *** p < 0.001. OPLL, ossification of posterior longitudinal ligament; CSM, cervical spondylotic myelopathy; SD, standard deviation; BMI, body mass index; ADL, activities of daily living.
Systemic complications, reoperation, and blood transfusion after matching.
| After Propensity Score-Matching | |||
|---|---|---|---|
| OPLL ( | CSM ( | ||
| Systemic complications | |||
| At least one complication | 148 (12.4%) | 146 (12.2%) | 0.90 |
| Cardiovascular disease | 32 (2.7%) | 35 (2.9%) | 0.71 |
| Cerebrovascular disease | 9 (0.8%) | 9 (0.8%) | >0.99 |
| Respiratory failure | 13 (1.1%) | 16 (1.3%) | 0.58 |
| Pneumonia | 11 (0.9%) | 13 (1.1%) | 0.68 |
| Dysphagia | 26 (2.2%) | 25 (2.1%) | 0.89 |
| Renal failure | 3 (0.3%) | 0 (0%) | 0.08 |
| Hepatic failure | 2 (0.2%) | 6 (0.5%) | 0.16 |
| Deep venous thrombosis | 3 (0.3%) | 7 (0.6%) | 0.21 |
| Pulmonary embolism | 1 (0.1%) | 0 (0%) | 0.32 |
| Sepsis | 2 (0.2%) | 6 (0.5%) | 0.16 |
| Delirium | 3 (0.3%) | 3 (0.3%) | >0.99 |
| Reoperation | |||
| At least one operation | 11 (0.9%) | 9 (0.8%) | 0.65 |
| Cardiac | 1 (0.1%) | 2 (0.2%) | 0.56 |
| Cerebral | 0 (0%) | 2 (0.2%) | 0.16 |
| Gastric (including endoscope) | 6 (0.5%) | 1 (0.1%) | 0.06 |
| Vena cava filter | 0 (0%) | 0 (0%) | NA |
| Tracheoplasty or Tracheotomy | 4 (0.3%) | 3 (0.3%) | 0.71 |
| Shunt form | 0 (0%) | 1 (0.1%) | 0.32 |
| Blood transfusion | 88 (7.4%) | 67 (5.6%) | 0.08 |
Data are presented as n (%). OPLL, ossification of posterior longitudinal ligament; CSM, cervical spondylotic myelopathy; NA, not applicable.
Local complications and reoperation after matching.
| After Propensity Score-Matching | |||
|---|---|---|---|
| OPLL ( | CSM ( | ||
| Local complications | |||
| At least one complication | 73 (6.1%) | 35 (2.9%) | <0.001 *** |
| Surgical site infection | 25 (2.1%) | 11 (0.9%) | 0.019 * |
| Paralysis | 14 (1.2%) | 9 (0.8%) | 0.30 |
| Meningitis | 2 (0.2%) | 0 (0%) | 0.16 |
| Spinal fluid leakage | 32 (2.7%) | 4 (0.3%) | <0.001 *** |
| Hematoma | 7 (0.6%) | 12 (1.0%) | 0.25 |
| Reoperation | |||
| At least one reoperation | 26 (2.2%) | 9 (0.8%) | 0.004 ** |
| Treatment for wound trouble | 21 (1.8%) | 9 (0.8%) | 0.027 * |
| Closure for fluid leakage | 5 (0.4%) | 0 (0%) | 0.025 * |
| Debridement | 0 (0%) | 0 (0%) | NA |
Data are presented as n (%). Significant values are given as follows. * p < 0.05, ** p < 0.01, *** p < 0.001. OPLL, ossification of posterior longitudinal ligament; CSM, cervical spondylotic myelopathy; NA, not applicable.
Cost, mortality, and ADL score for discharge after matching.
| After Propensity Score-Matching | |||
|---|---|---|---|
| OPLL ( | CSM ( | ||
| Cost (mean ± SD) ($) | 23,164 ± 11,134 | 19,993 ± 10,629 | <0.001 *** |
| Mortality | 1 (0.1%) | 2 (0.2%) | 0.56 |
| ADL score for discharge (points) | 17.6 ± 4.5 | 17.8 ± 4.4 | 0.42 |
Data were presented as n (%) or mean ± SD. Significant values are given as follows. *** p < 0.001. OPLL, ossification of posterior longitudinal ligament; CSM, cervical spondylotic myelopathy; SD, standard deviation; ADL, activities of daily living.
Cost between complication (+) and (−) in OPLL and CSM after matching.
| OPLL ( | Systemic Complication (+) ( | Systemic Complication (−) ( | |
|---|---|---|---|
| Cost ($) | 26,920 ± 15,337 | 21,714 ± 9769 | <0.001 *** |
| Local complication (+) ( | Local complication (−) ( | ||
| Cost ($) | 26,115 ± 12,645 | 22,113 ± 10,572 | 0.002 ** |
| Total complication (+) ( | Total complication (−) ( | ||
| Cost ($) | 26,701 ± 14,742 | 21,438 ± 9449 | <0.001 *** |
|
|
|
|
|
| Cost ($) | 25,013 ± 18,793 | 18,502 ± 8120 | <0.001 *** |
| Local complication (+) ( | Local complication (−) ( | ||
| Cost ($) | 21,852 ± 8758 | 19,219 ± 10,294 | 0.13 |
| Total complication (+) ( | Total complication (−) ( | ||
| Cost ($) | 24,508 ± 17,514 | 18,392 ± 8063 | <0.001 *** |
Data were presented as mean ± SD. Significant values are given as follows. ** p < 0.01, *** p < 0.001. OPLL, ossification of posterior longitudinal ligament; CSM, cervical spondylotic myelopathy; SD, standard deviation.